Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robin B Jarrett

Showing results (51-60 of 88) with videos related to

Pageof 9
Sort By:
Journal of Consulting and Clinical Psychology|July 22, 2014
Stable remission and recovery after acute-phase cognitive therapy for recurrent major depressive disorderJeffrey R Vittengl, Lee Anna Clark, Michael E Thase, et al.
Psychiatry Research|April 8, 2017
Initial Steps to inform selection of continuation cognitive therapy or fluoxetine for higher risk responders to cognitive therapy for recurrent major depressive disorderJeffrey R Vittengl, Lee Anna Clark, Michael E Thase, et al.
Behaviour Research and Therapy|August 3, 2020
Do patients' cognitive therapy skills predict personality change during treatment of depression?Jeffrey R Vittengl, Lee Anna Clark, Michael E Thase, et al.
Clinical Psychology Review|March 11, 2015
A lifetime approach to major depressive disorder: The contributions of psychological interventions in preventing relapse and recurrenceClaudi L Bockting, Steven D Hollon, Robin B Jarrett, et al.
JAMA Psychiatry|September 6, 2013
Preventing depressive relapse and recurrence in higher-risk cognitive therapy responders: a randomized trial of continuation phase cognitive therapy, fluoxetine, or matched pill placeboRobin B Jarrett, Abu Minhajuddin, Howard Gershenfeld, et al.
Journal of Affective Disorders|September 24, 2020
Quality of life after response to acute-phase cognitive therapy for recurrent depressionJeffrey R Vittengl, Manish K Jha, Abu Minhajuddin, et al.
Journal of Autism and Developmental Disorders|June 10, 2021
Mindful Self-Care for Caregivers: A Proof of Concept Study Investigating a Model for Embedded Caregiver Support in a Pediatric SettingKatherine M Bellone, Stephen C Elliott, Linda S Hynan, et al.
Journal of Consulting and Clinical Psychology|December 15, 2015
Quantifying and qualifying the preventive effects of acute-phase cognitive therapy: Pathways to personalizing careRobin B Jarrett, Abu Minhajuddin, Jeffrey R Vittengl, et al.
Behavior Therapy|April 1, 2014
Extreme nonresponse to acute phase cognitive therapy for depression: an attempt to replicate and extendAaron M Koenig, Robin B Jarrett, Robert Gallop, et al.
Journal of Affective Disorders|September 8, 2009
Which depressive symptoms remain after response to cognitive therapy of depression and predict relapse and recurrence?Daniel J Taylor, Heather M Walters, Jeffrey R Vittengl, et al.
Pageof 9

Showing results (51-60 of 88) with videos related to

Sort By:
Pageof 9
Journal of Consulting and Clinical Psychology|July 22, 2014
Stable remission and recovery after acute-phase cognitive therapy for recurrent major depressive disorderJeffrey R Vittengl, Lee Anna Clark, Michael E Thase, et al.
Psychiatry Research|April 8, 2017
Initial Steps to inform selection of continuation cognitive therapy or fluoxetine for higher risk responders to cognitive therapy for recurrent major depressive disorderJeffrey R Vittengl, Lee Anna Clark, Michael E Thase, et al.
Behaviour Research and Therapy|August 3, 2020
Do patients' cognitive therapy skills predict personality change during treatment of depression?Jeffrey R Vittengl, Lee Anna Clark, Michael E Thase, et al.
Clinical Psychology Review|March 11, 2015
A lifetime approach to major depressive disorder: The contributions of psychological interventions in preventing relapse and recurrenceClaudi L Bockting, Steven D Hollon, Robin B Jarrett, et al.
JAMA Psychiatry|September 6, 2013
Preventing depressive relapse and recurrence in higher-risk cognitive therapy responders: a randomized trial of continuation phase cognitive therapy, fluoxetine, or matched pill placeboRobin B Jarrett, Abu Minhajuddin, Howard Gershenfeld, et al.
Journal of Affective Disorders|September 24, 2020
Quality of life after response to acute-phase cognitive therapy for recurrent depressionJeffrey R Vittengl, Manish K Jha, Abu Minhajuddin, et al.
Journal of Autism and Developmental Disorders|June 10, 2021
Mindful Self-Care for Caregivers: A Proof of Concept Study Investigating a Model for Embedded Caregiver Support in a Pediatric SettingKatherine M Bellone, Stephen C Elliott, Linda S Hynan, et al.
Journal of Consulting and Clinical Psychology|December 15, 2015
Quantifying and qualifying the preventive effects of acute-phase cognitive therapy: Pathways to personalizing careRobin B Jarrett, Abu Minhajuddin, Jeffrey R Vittengl, et al.
Behavior Therapy|April 1, 2014
Extreme nonresponse to acute phase cognitive therapy for depression: an attempt to replicate and extendAaron M Koenig, Robin B Jarrett, Robert Gallop, et al.
Journal of Affective Disorders|September 8, 2009
Which depressive symptoms remain after response to cognitive therapy of depression and predict relapse and recurrence?Daniel J Taylor, Heather M Walters, Jeffrey R Vittengl, et al.
Pageof 9